Paraneoplastic isolated myelopathy: Clinical course and neuroimaging clues

Neurology

Volumn 76, Issue 24, 2011, Pages 2089-2095

  Flanagan, E P ^a   McKeon, A ^a,b   Lennon, V A ^a,b,c   Kearns, J ^a   Weinshenker, B G ^a   Krecke, K N ^d   Matiello, M ^a   Keegan, B M ^a   Mokri, B ^a   Aksamit, A J ^a   Pittock, S J ^a,b  

^a MAYO CLINIC   (United States)

^b Brain Tumor Institute   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

^d Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIPHYSIN; AUTOANTIBODY; AZATHIOPRINE; COLLAPSIN RESPONSE MEDIATOR PROTEIN; COLLAPSIN RESPONSE MEDIATOR PROTEIN 5; CYCLOPHOSPHAMIDE; GADOLINIUM; HU ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OLIGOCLONAL BAND; STEROID; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; ENDOMETRIUM CARCINOMA; GRAY MATTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; LUNG CARCINOMA; MELANOMA; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OVARY CARCINOMA; PARANEOPLASTIC ISOLATED MYELOPATHY; PHENOTYPE; PLASMAPHERESIS; PLEOCYTOSIS; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; SPINAL CORD DISEASE; SYSTEMATIC REVIEW; THYROID CARCINOMA;

EID: 79959660071     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31821f468f     Document Type: Article

References (35)

1. Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann Neurol 2005;58:96-107. (Pubitemid 40962465)
2. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol 2003;53:580-587. (Pubitemid 36529431)
3. Chan KH, Vernino S, Lennon VA. ANNA-3 antineuronal nuclear antibody: marker of lung cancer-related autoimmunity. Ann Neurol 2001;50:301-311. (Pubitemid 32848732)
4. Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 2001;49:146-154. (Pubitemid 32157990)
5. Sillevis Smitt P, Grefkens J, de Leeuw B, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 2002;249:745-753. (Pubitemid 34651757)
6. Graus F, Keime-Guibert F, Rene R, et al. Anti-Huassociated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124:1138-1148. (Pubitemid 32510382)
7. Vernino S, Lennon VA. New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 2000;47:297-305. (Pubitemid 30141838)
8. Tracy JLV, Pittock SJ. Purkinje cell antibody type 1 (PCA-1, Anti-Yo): peripheral nerve manifestations. Neurology 2006;66:188.
9. Hoffmann LA, Jarius S, Pellkofer HL, et al. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 2008;79:767-773. (Pubitemid 351914721)
10. Rajabally YA, Qaddoura B, Abbott RJ. Steroid-responsive paraneoplastic demyelinating neuropathy and myelopathy associated with breast carcinoma. J Clin Neuromuscul Dis 2008;10:65-69.
11. Graber JJ, Nolan CP. Myelopathies in patients with cancer. Arch Neurol 2010;67:298-304.
12. Graus F, Vincent A, Pozo-Rosich P, et al. Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol 2005;165: 166-171. (Pubitemid 40984634)
13. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004;56:715-719. (Pubitemid 39540753)
14. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000;343:847-855.
15. Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 1998;50:1806-1813. (Pubitemid 28283256)
16. Pittock SJ, Yoshikawa H, Ahlskog JE, et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 2006; 81:1207-1214. (Pubitemid 44316286)
17. Griesmann GE, Kryzer TJ, Lennon VA. Autoantibody profiles of myasthenia gravis and Lambert-Eaton myasthenic syndrome. In: Rose NR, Hamilton RG, Detrick B, eds. Manual of Clinical and Laboratory Immunology, 6th ed. Washington, DC: ASM Press; 2002:1005-1012.
18. Glantz MJ, Biran H, Myers ME, Gockerman JP, Friedberg MH. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 1994;73: 168-175. (Pubitemid 24012739)
19. Leypoldt F, Eichhorn P, Saager C, Munchau A, Lewerenz J. Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis. J Neurol Neurosurg Psychiatry 2006;77:1199-1200. (Pubitemid 44453262)
20. Masson C, Pruvo JP, Meder JF, et al. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry 2004; 75:1431-1435. (Pubitemid 39279812)
21. Hundsberger T, Thomke F, Hopf HC, Fitzek C. Symmetrical infarction of the cervical spinal cord due to spontaneous bilateral vertebral artery dissection. Stroke 1998;29: 1742. (Pubitemid 28365605)
22. Krampla W, Aboul-Enein F, Jecel J, et al. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur Radiol 2009;19: 2535-2543.
23. Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lucking CH. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry 1998;65:822-827. (Pubitemid 128710420)
24. Pradhan S, Yadav R, Mishra VN, Aurangabadkar K, Sawlani V. Amyotrophic lateral sclerosis with predominant pyramidal signs: early diagnosis by magnetic resonance imaging. Magn Reson Imaging 2006;24:173-179. (Pubitemid 43175756)
25. Loughrey GJ, Collins CD, Todd SM, Brown NM, Johnson RJ. Magnetic resonance imaging in the management of suspected spinal canal disease in patients with known malignancy. Clin Radiol 2000;55:849-855. (Pubitemid 32054640)
26. Metser U, Lerman H, Blank A, Lievshitz G, Bokstein F, Even-Sapir E. Malignant involvement of the spine: assessment by 18F-FDG PET/CT. J Nucl Med 2004;45:279-284. (Pubitemid 47618649)
27. McKeon A, Apiwattanakul M, Lachance DH, et al. Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: systematic analysis and review. Arch Neurol 2010;67:322-329.
28. Junger SS, Stern BJ, Levine SR, Sipos E, Marti-Masso JF. Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology 1993;43: 333-337. (Pubitemid 23060264)
29. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study: I: clinical course and disability. Brain 1989;112:133-146. (Pubitemid 19056478)
30. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846. (Pubitemid 41746873)
31. Scott TF, Bhagavatula K, Snyder PJ, Chieffe C. Transverse myelitis: comparison with spinal cord presentations of multiple sclerosis. Neurology 1998;50:429-433.
32. Anderson DW, Borsaru A. Case report: lymphoma-related resolving paraneoplastic myelopathy with MRI correlation. Br J Radiol 2008;81:e103-e105.
33. Keegan BM, Pittock SJ, Lennon VA. Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol 2008;63:531-534. (Pubitemid 351614719)
34. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776-785.
35. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.